Endometriosis: recurrence and retreatment
- PMID: 1286484
Endometriosis: recurrence and retreatment
Abstract
Endometriosis, a condition in which endometrial tissue sheds and becomes attached to extrauterine sites, appears to be a progressive or recurrent disease. Although there are a variety of treatment options, the only cure for endometriosis is total abdominal hysterectomy with bilateral oophorectomy. For women who wish to preserve fertility, however, this is not a desirable choice. Because the symptoms of endometriosis suggest a hormonal relationship, pharmacologic management entails inducing anovulation. A concern of both physicians and patients is recurrence of endometriosis after initial response to therapy. Whether symptoms represent recurrent disease or progression of preexisting implants is still unknown. A repeat course of therapy with danazol, a synthetic androgen, may be tried for retreatment of endometriosis. Another option is the progestins. Conservative surgery (ie, laparoscopy) is also an option, but often must be repeated for pain control; combination pharmacologic/surgical therapy, although in widespread use, is not without disadvantages and requires further investigation.
Similar articles
-
Pharmacologic management of endometriosis.Clin Pharm. 1991 Jul;10(7):518-31. Clin Pharm. 1991. PMID: 1830521 Review.
-
Diagnosis and treatment of endometriosis. A review.Minerva Ginecol. 2005 Feb;57(1):55-78. Minerva Ginecol. 2005. PMID: 15758866 Review. English, Italian.
-
Endometriosis: approaches to diagnosis and treatment.Surg Annu. 1984;16:297-312. Surg Annu. 1984. PMID: 6374940 Review.
-
Repetitive surgery for recurrent symptomatic endometriosis: what to do?Eur J Obstet Gynecol Reprod Biol. 2009 Sep;146(1):15-21. doi: 10.1016/j.ejogrb.2009.05.007. Epub 2009 May 30. Eur J Obstet Gynecol Reprod Biol. 2009. PMID: 19482404 Review.
-
Second-look laparoscopy in the treatment of endometriosis.Int J Fertil. 1988 Jul-Aug;33(4):237-40. Int J Fertil. 1988. PMID: 2902036
Cited by
-
Progesterone Actions and Resistance in Gynecological Disorders.Cells. 2022 Feb 13;11(4):647. doi: 10.3390/cells11040647. Cells. 2022. PMID: 35203298 Free PMC article. Review.
-
Efficacy of niclosamide on the intra-abdominal inflammatory environment in endometriosis.FASEB J. 2021 May;35(5):e21584. doi: 10.1096/fj.202002541RRR. FASEB J. 2021. PMID: 33860549 Free PMC article.
-
Niclosamide As a Potential Nonsteroidal Therapy for Endometriosis That Preserves Reproductive Function in an Experimental Mouse Model.Biol Reprod. 2016 Oct 1;95(4):76. doi: 10.1095/biolreprod.116.140236. Epub 2016 Aug 17. Biol Reprod. 2016. PMID: 27535961 Free PMC article.
-
Endometriotic inflammatory microenvironment induced by macrophages can be targeted by niclosamide†.Biol Reprod. 2019 Feb 1;100(2):398-408. doi: 10.1093/biolre/ioy222. Biol Reprod. 2019. PMID: 30329025 Free PMC article.
-
Niclosamide suppresses macrophage-induced inflammation in endometriosis†.Biol Reprod. 2020 Apr 24;102(5):1011-1019. doi: 10.1093/biolre/ioaa010. Biol Reprod. 2020. PMID: 31950153 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical